Novel conformationally constrained pyrazole derivatives as potential anti-cancer agents
作者:Konstantinos M. Kasiotis、Evangelia N. Tzanetou、Dimitrios Stagos、Nikolas Fokialakis、Eleni Koutsotheodorou、Dimitrios Kouretas、Serkos A. Haroutounian
DOI:10.1515/znb-2015-0053
日期:2015.9.1
Abstract The synthesis of 17 novel conformationally constrained pyrazole derivatives is reported herein, along with the assessment of their anti-proliferative and anti-angiogenic activities. The evaluation of their inhibitory effect on cell proliferation against HepG2, HeLa, and MCF-7 cells revealed the pyrrolo[2,3-g]indazole 23 as a potent inhibitor of cell growth with IC50 values of 5 μm. Additionally
摘要 本文报道了 17 种新型构象受限吡唑衍生物的合成,以及对其抗增殖和抗血管生成活性的评估。对它们对 HepG2、HeLa 和 MCF-7 细胞增殖抑制作用的评估表明,吡咯并 [2,3-g] 吲唑 23 是一种有效的细胞生长抑制剂,IC50 值为 5 μm。此外,证明了 HeLa 上清细胞中吡唑 20 和 23(分别为 30% 和 35%)对血管内皮生长因子的抑制作用。这些发现强调了这些化合物作为潜在支架的有用性,用于设计和开发具有显着抗血管生成活性的新型抗癌剂。